Your health data exists. You just can't get to it.
Test results in one portal. Notes in another. Specialists who've never spoken to each other. Vana Healthcare gives you one place to hold it all — and puts you in charge of who else gets to see it. Same data. Finally working for you.
Joining the waitlist takes less than a minute — no credit card, ever.
Meet Vee — the daily check-in that turns care into data, and data into care
No fine print you need a lawyer for. Here's exactly what happens when you check in.
Check in with Vee
A friendly daily check-in on symptoms, meds, and labs — thirty seconds, not a survey. Vee remembers, so you don't have to repeat yourself.
Vee builds your record
Every check-in becomes part of one connected, plain-language record — replacing the dozen disconnected portals you're used to.
You decide what's shared
Nothing leaves your record without your say-so. Consent is granted per data type — labs, meds, symptoms — and you can revoke it anytime.
Your data can help close the gap for others
With your consent, it can support research and drug development that's never had real access to people like you. Free to you — funded by the partners who license it, not by you.
Your digital twin, right on your home screen
The idea: your avatar's condition mirrors yours. Skip a check-in or run a fever, and Vee looks a little under the weather too — so caring for it means caring for the record that helps you and the research that could help someone else.
Synced with your wearables. Glucose monitors, smartwatches, rings — the numbers you're already generating, pulled into one simple view instead of five different apps.
A reason to come back daily. Streaks, points, and a friendly nudge to take your meds — the same habit-forming mechanics that make Duolingo hard to quit, aimed at something that actually matters.
Someone to talk to. Vee isn't just a data form — it's a check-in on how you're actually doing, with support for the harder days too.
Conceptual mockup — current design in progress, not yet available.
This is what the data gap actually costs people
Three views of the same problem — from the people living it, the people caring for them, and the people trying to study it.
Every new specialist means repeating your story from scratch — symptoms, timelines, medications, all of it, again. Vana Healthcare means you tell it once.
You're the one holding the binder, the portal logins, the timeline no single doctor has time to read in full. Vana Healthcare keeps it in one place — built for you, not just about the person you're caring for.
Researchers studying rare and complex conditions have always needed real-world, longitudinal patient data. It's existed the whole time — just never connected, never consented at the source, never actually accessible. Vana Healthcare is how that changes.
Built first for multiple myeloma and its precursor conditions — the wedge, not the ceiling
Right now, 19 active post-marketing studies are tracking the newest wave of multiple myeloma treatments — bispecific antibodies and CAR-T therapies approved between 2021 and 2024, sponsored directly by companies like Regeneron and Johnson & Johnson. Vana Healthcare starts earlier in that same journey: with the years of watch-and-wait monitoring patients live through with MGUS and smoldering myeloma, long before — and long after — a diagnosis of active disease.
Source: ClinicalTrials.gov, live trial search, August 2026.
Ownership isn't a slogan here — it's how the product works
Every design decision starts from one rule: it's your data, so you decide.
You approve every share, every time — not a blanket privacy setting, an actual decision you make.
Encrypted, and never sold. Vana doesn't make money by selling your data to advertisers or brokers.
Leave anytime, no penalty. Delete your data or close your account whenever you want — no dark patterns.
Free to you, because pharma funds it. Vana Healthcare doesn't charge patients. Research and pharma partners pay for consented, de-identified insights — only with your explicit permission.
Why give your data
Vana Healthcare might not undo years of searching for the right diagnosis. But the data you choose to share today could be the reason someone else's search takes months, not years. Reducing suffering in healthcare, one consented data point at a time — that's the whole point.
The post-marketing data you're already funding — just not from a source like this
Vana Healthcare starts in multiple myeloma and its precursor conditions, where newly approved bispecific antibodies and CAR-T therapies carry active, sponsor-funded post-marketing commitments — 19 Phase 4 studies are running right now, funded by companies like Regeneron and Johnson & Johnson. We deliver structured, consented, longitudinal patient data spanning years before diagnosis through treatment and beyond — not a claims extract assembled after the fact.
Partner / institution logos go here once confirmed
Common questions
Is my data ever sold? +
No. Never. Vana doesn't make money by selling personal data to advertisers, employers, or insurers. (Full data policy link — placeholder, add before launch.)
Do I have to share everything? +
No — you choose exactly what's shared and with whom, section by section. You can share your medication history with a researcher and nothing else, for example.
Is Vana a hospital or insurance company? +
No. Vana doesn't provide medical care or coverage. Think of it as your own health data home base that sits alongside your existing care team.
What if I have a common condition, not a rare one? +
Vana works for anyone who wants to own and understand their health data. Rare and complex conditions are where we started — not where we stop.
How is my data kept secure? +
Vana Healthcare is built on HIPAA-aligned infrastructure — encrypted at rest and in transit, with signed data agreements in place with every partner and vendor. A SOC 2 audit is part of our early roadmap, not an afterthought.